Published in Healthcare Finance, Tax and Law Weekly, July 25th, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at MIV Therapeutics.
Report 1: News; FWB:MIV), a leading developer of next generation biocompatible coatings and advanced drug delivery systems for Cardiovascular stents and other implantable medical devices, has announced that Dr. Daljeet Singh Gambhir, Director of Cardiology and Chief Executive Officer of the Kailash Heart Institute, has been appointed to the Company's Medical Advisory Board and will hold the position of Clinical Advisor to MIVT India.
In the position,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Finance, Tax and Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.